Reversal of Sjogren's-like syndrome in non-obese diabetic mice - sprookjes - yvandenbroek - TriplyDB

Reversal of Sjogren's-like syndrome in non-obese diabetic mice

Reversal of Sjogren's-like syndrome in non-obese diabetic mice

http://www.wikidata.org/entity/Q24674948

about

Quantitative analysis of protein and gene expression in salivary glands of Sjogren's-like disease NOD mice treated by bone marrow soup Effect of mesenchymal stem cells on Sjögren-like mice and the microRNA expression profiles of splenic CD4+ T cells Proteomics identifies multipotent and low oncogenic risk stem cells of the spleen.Interferon-γ induces immunoproteasomes and the presentation of MHC I-associated peptides on human salivary gland cells.Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sjögren's-like disease Splenocytes seed bone marrow of myeloablated mice: implication for atherosclerosis.Bone marrow-derived cells rescue salivary gland function in mice with head and neck irradiation.Bone marrow cells are a source of undifferentiated cells to prevent Sjögren's syndrome and to preserve salivary glands function in the non-obese diabetic mice Resveratrol improves salivary dysfunction in a non-obese diabetic (NOD) mouse model of Sjögren's syndrome.TNF Receptor 2 and Disease: Autoimmunity and Regenerative Medicine.Stem cells in the spleen: therapeutic potential for Sjogren's syndrome, type I diabetes, and other disorders.Autonomous isolation, long-term culture and differentiation potential of adult salivary gland-derived stem/progenitor cells.Cell extracts from spleen and adipose tissues restore function to irradiation-injured salivary glands.Anti-IL-7 receptor-α treatment ameliorates newly established Sjögren's-like exocrinopathy in non-obese diabetic mice.The Spleen as an Optimal Site for Islet Transplantation and a Source of Mesenchymal Stem Cells.

P2860

Q28539302-CC45E3B1-2CE2-4CCD-A688-73363B48BEAB Q33744508-8627DC12-FD4E-4513-85B2-6B7BF54C6EDF Q33937536-0301E2FB-F984-4ABF-87B8-311231129A60 Q34015431-24FDF9EF-D8AA-4BA2-B1F0-B99D56FE12E8 Q34299698-E67B8FC3-04FA-49B9-96D8-AEAAF42DC197 Q35650810-A6C3BCDC-31BF-4700-A6D9-BBE6E9CFE7E0 Q36112363-D40A45BF-7A21-4AA0-8A6F-ED5709B29101 Q36925952-E48F90BE-0EFA-4419-BFA4-9D59FF13C63F Q37247050-62E62CEA-3024-4B69-859E-600B4C1733E8 Q37408682-11531B17-CD6E-4F0F-8779-BB68653F0993 Q37769927-4C4399AD-3F2C-49A7-ADF3-57B9A79A2957 Q43873165-B2A12BDE-B6E9-4F90-AD25-81278DF04490 Q47311157-3D8FCCF2-52C2-4961-89B3-67EE1DDB2996 Q52572230-C78C4308-C13F-4511-8720-487635902B30 Q55024614-B8F865DD-8A0C-427B-80CF-93623C8C8D79

P2860

Reversal of Sjogren's-like syndrome in non-obese diabetic mice

http://www.wikidata.org/entity/Q24674948

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Reversal of Sjogren's-like syndrome in non-obese diabetic mice

@ast

Reversal of Sjogren's-like syndrome in non-obese diabetic mice

@en

Reversal of Sjogren's-like syndrome in non-obese diabetic mice

@nl

type

label

Reversal of Sjogren's-like syndrome in non-obese diabetic mice

@ast

Reversal of Sjogren's-like syndrome in non-obese diabetic mice

@en

Reversal of Sjogren's-like syndrome in non-obese diabetic mice

@nl

prefLabel

Reversal of Sjogren's-like syndrome in non-obese diabetic mice

@ast

Reversal of Sjogren's-like syndrome in non-obese diabetic mice

@en

Reversal of Sjogren's-like syndrome in non-obese diabetic mice

@nl

P1433

Q24674948-D9B6C4E7-ABA8-455E-B8A6-EB0AB2E83347

P1476

Q24674948-D2B3E450-EE10-4D6A-9C89-B145D2829495

P2093

Q24674948-0BC996E2-C9B3-4999-B837-745C6C6558A8

Q24674948-27BFCB9D-5B68-4AE5-BA8F-3E0A719382A8

Q24674948-41F16D9A-EEA6-4820-AB24-B61657274FCA

Q24674948-64D05189-4090-441F-922A-3476C5940018

Q24674948-7ED384AC-7A25-4056-8EDB-45D605FF18A5

Q24674948-BAB56CC5-83CC-400B-8AEE-56DC2452101A

Q24674948-C0896184-78E1-4C31-852B-0009E3E8383A

Q24674948-C20D3A58-C157-4020-AEF8-CCBA2500D8FE

P2860

Q24674948-050E337B-89C9-4D15-8F7A-D53290785745

Q24674948-101E1853-BD4D-46DA-83B2-5A593BB260EF

Q24674948-1CFAD951-C7C1-48D9-B6C2-0953A00F9491

Q24674948-1E1D55A6-C377-483E-BE90-07BD604E65F2

Q24674948-8FDC2C6A-3D7B-4F75-BB05-A18540618C1D

Q24674948-A587776F-549B-4794-B3C6-72BC6123E5D4

Q24674948-AC2CFBAF-E6A3-4003-AE4E-E641E88E15D6

Q24674948-B25D8D28-01D0-45FA-9893-A87C177832CD

Q24674948-B2E4D8FD-5180-4D9D-973D-43093ADAB72A

Q24674948-CC239CC4-5BF7-45ED-8B6B-3AE7F8B45685

P304

Q24674948-F7890D8F-9FD0-4CE6-98E3-4AB1DF05E608

P31

Q24674948-F783548C-47AF-45E3-BE7D-1ED7C2830B46

Q24674948-d4113f81-277f-4086-9262-7052dbc69b75

P3181

Q24674948-558FB3D6-EAD7-4303-B546-61FF4980E3E5

P356

Q24674948-6D514125-05FB-48DD-94D3-0835A193F7F3

P407

Q24674948-3465A795-ED3E-4493-878B-55900B4701B3

P433

Q24674948-52A72930-3945-49CF-9895-AA883CB8D3E3

P478

Q24674948-8B2C2074-06F0-4593-BE75-D127B08516A6

P577

Q24674948-AEC57356-F925-4FA3-97A3-57E6E868CC96

P5875

Q24674948-2C0C3ECD-4540-4978-B707-1AC2A321F88D

P698

Q24674948-3BC58713-1390-443E-896A-CF99C94B1534

P921

Q24674948-E014AA20-2987-4E6F-903C-0386BBB92EC5

P932

Q24674948-22F9D210-7F04-444A-B8F9-939C8F4C4DEF

P3181

P356

ARD.2006.064030

P1433

Annals of the Rheumatic Diseases

P1476

Reversal of Sjogren's-like syndrome in non-obese diabetic mice

@en

P2093

Beatrijs M Lodde

http://www.w3.org/2001/XMLSchema#string

Denise L Faustman

http://www.w3.org/2001/XMLSchema#string

Eva Mezey

http://www.w3.org/2001/XMLSchema#string

Ildiko Szalayova

http://www.w3.org/2001/XMLSchema#string

Saeed Khalili

http://www.w3.org/2001/XMLSchema#string

Sharon Key

http://www.w3.org/2001/XMLSchema#string

Shohta Kodama

http://www.w3.org/2001/XMLSchema#string

Simon D Tran

http://www.w3.org/2001/XMLSchema#string

P2860

Reversal of established autoimmune diabetes by restoration of endogenous beta cell function

The NOD mouse model of type 1 diabetes: as good as it gets?

Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow.

NOD mice are defective in proteasome production and activation of NF-kappaB

Islet regeneration during the reversal of autoimmune diabetes in NOD mice.

Comment on papers by Chong et al., Nishio et al., and Suri et al. on diabetes reversal in NOD mice.

Immunoproteasome subunit LMP2 expression is deregulated in Sjogren's syndrome but not in other autoimmune disorders.

Most classical Mus musculus domesticus laboratory mouse strains carry a Mus musculus musculus Y chromosome.

Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.

Immune responses following salivary gland administration of recombinant adeno-associated virus serotype 2 vectors.

P304

812-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3991378

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/ARD.2006.064030

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6621409

http://www.w3.org/2001/XMLSchema#string

P698

17179174

http://www.w3.org/2001/XMLSchema#string

P921

P932

1954678

http://www.w3.org/2001/XMLSchema#string